Abstract
Background and study aims
Fatty pancreas is a potential risk factor for acute pancreatitis; however, whether it is also a risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) has not been evaluated. We aimed to determine the impact of fatty pancreas on the development of PEP.
Methods
We analyzed the data of patients who underwent abdominal computed tomography (CT) scan and sequential therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Fatty change in the pancreas was evaluated based on pancreatic attenuation of unenhanced image on CT scan. The risk of fatty pancreas for the development of PEP was evaluated using a logistic regression model.
Results
Of a total of 858 patients included in the study, 354 (41.3%) had fatty pancreas, while 504 (58.7%) did not have fatty pancreas. PEP developed in 28 patients (7.9%) in the fatty pancreas group and in 13 patients (2.6%) in the no fatty pancreas group. Fatty pancreas was significantly associated with the development of PEP (odds ratio [OR] [95% confidence interval [CI]] 2.38 [1.16–4.87]). A history of acute pancreatitis, female sex, difficult cannulation, and endoscopic papillary balloon dilation were also risk factors for the development of PEP. The risk for moderate-to-severe PEP development tended to be higher in the fatty pancreas group than in the no fatty pancreas group (OR [95% CI] 5.61 [0.63–49.62]).
Conclusions
Fatty pancreas is a significant risk factor for the development of PEP. Clinicians need to be aware of the risk of fatty pancreas for the development of PEP prior to performing ERCP.
Similar content being viewed by others
References
ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM (2017) Adverse events associated with ERCP. Gastrointest Endosc 85:32–47
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM (1996) Complications of endoscopic biliary sphincterotomy. N Engl J Med 335:909–918
Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10
Masci E, Mariani A, Curioni S, Testoni PA (2003) Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35:830–834
Chen JJ, Wang XM, Liu XQ, Li W, Dong M, Suo ZW, Ding P, Li Y (2014) Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. Eur J Med Res 19:26
Morales SJ, Sampath K, Gardner TB (2018) A review of prevention of post-ERCP pancreatitis. Gastroenterol Hepatol 14:286–292
Navina S, Acharya C, DeLany JP, Orlichenko LS, Baty CJ, Shiva SS, Durgampudi C, Karlsson JM, Lee K, Bae KT, Furlan A, Behari J, Liu S, McHale T, Nichols L, Papachristou GI, Yadav D, Singh VP (2011) Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 3:107–110
Acharya C, Cline RA, Jaligama D, Noel P, Delany JP, Bae K, Furlan A, Baty CJ, Karlsson JM, Rosario BL, Patel K, Mishra V, Dugampudi C, Yadav D, Navina S, Singh VP (2013) Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology 145:466–475
Deng LH, Xue P, Xia Q, Yang XN, Wan MH (2008) Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J Gastroenterol 14:4558–4561
Lloret Linares C, Pelletier AL, Czernichow S, Vergnaud AC, Bonnefont-Rousselot D, Levy P, Ruszniewski P, Bruckert E (2008) Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 37:13
Singh VP, Bhagat L, Navina S, Sharif R, Dawra RK, Saluja AK (2007) Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut 56:958–964
Dawra R, Sah RP, Dudeja V, Rishi L, Talukdar R, Garg P, Saluja AK (2011) Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis. Gastroenterology 141:2210–2217
Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, Mehta G, Chuttani R, Kane R, Pleskow D, Sawhney MS (2011) A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 73:987–993
Park CH, Jung JH, Hyun B, Kan HJ, Lee J, Kae SH, Jang HJ, Koh DH, Choi MH, Chung MJ, Bang S, Park SW (2018) Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial. Gastrointest Endosc 87:1040–1049
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37:383–393
de Tejada AH, Calleja JL, Diaz G, Pertejo V, Espinel J, Cacho G et al (2009) Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest Endosc 70:700–709
Park CH, Jung JH, Nam E, Kim EH, Kim MG, Kim JH, Park SW (2018) Comparative efficacy of various endoscopic techniques for the treatment of common bile duct stones: a network meta-analysis. Gastrointest Endosc 87:43–57
Kim SY, Kim H, Cho JY, Lim S, Cha K, Lee KH, Kim YH, Kim JH, Yoon YS, Han HS, Kang HS (2014) Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 271:104–112
Sakai NS, Taylor SA, Chouhan MD (2018) Obesity, metabolic disease and the pancreas-Quantitative imaging of pancreatic fat. Br J Radiol 91:20180267
Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112
Wilcox CM, Phadnis M, Varadarajulu S (2010) Biliary stent placement is associated with post-ERCP pancreatitis. Gastrointest Endosc 72:546–550
Testoni PA, Mariani A, Giussani A, Vailati C, Masci E, Macarri G et al (2010) Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol 105:1753–1761
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA (2006) Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101:139–147
Friedland S, Soetikno RM, Vandervoort J, Montes H, Tham T, Carr-Locke DL (2002) Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 34:483–488
Tsujino T, Isayama H, Komatsu Y, Ito Y, Tada M, Minagawa N, Nakata R, Kawabe T, Omata M (2005) Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol 100:38–42
Acharya C, Navina S, Singh VP (2014) Role of pancreatic fat in the outcomes of pancreatitis. Pancreatology 14:403–408
Durgampudi C, Noel P, Patel K, Cline R, Trivedi RN, DeLany JP, Yadav D, Papachristou GI, Lee K, Acharya C, Jaligama D, Navina S, Murad F, Singh VP (2014) Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation. Am J Pathol 184:1773–1784
Funding
This research was supported by Hallym University Research Fund 2020 (HURF-2020-55).
Author information
Authors and Affiliations
Contributions
Guarantor of the article: SWP. SWP conceived and designed the study. MJC and SWP provided study materials or patients. CHP, MJC, DHP, SM, and SWP analyzed and interpreted the data. SWP and CHP drafted the article. SWP, SM, and CHP critically revised the article for important intellectual content. CHP performed the statistical analyses. All authors were responsible for conducting the study, including care of the patients, acquisition of the data, and interpretation of the data after analysis. After drafting of the initial manuscript, all authors critically revised the manuscript and approved the final version.
Corresponding author
Ethics declarations
Disclosures
Chan Hyuk Park, Moon Jae Chung, Da Hae Park, Seonjeong Min, and Se Woo Park have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Park, C.H., Chung, M.J., Park, D.H. et al. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis. Surg Endosc 36, 5734–5742 (2022). https://doi.org/10.1007/s00464-022-09070-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09070-8